|
BTBD9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.084390E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.016900E-03 |
| Normal-vs-Stage2 |
1.664200E-01 |
| Normal-vs-Stage3 |
1.815250E-03 |
| Normal-vs-Stage4 |
4.944800E-03 |
| Stage1-vs-Stage2 |
2.541600E-01 |
| Stage1-vs-Stage3 |
5.540000E-01 |
| Stage1-vs-Stage4 |
6.728600E-01 |
| Stage2-vs-Stage3 |
1.576960E-01 |
| Stage2-vs-Stage4 |
1.990780E-01 |
| Stage3-vs-Stage4 |
9.731200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.036890E-03 |
| Normal-vs-AfricanAmerican |
5.292000E-01 |
| Normal-vs-Asian |
1.044080E-02 |
| Caucasian-vs-AfricanAmerican |
1.048830E-01 |
| Caucasian-vs-Asian |
9.636000E-01 |
| AfricanAmerican-vs-Asian |
1.161580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.579200E-04 |
| Normal-vs-Female |
4.815600E-03 |
| Male-vs-Female |
1.254000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.403400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.063700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.351600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.878030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.088000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.995000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.729400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.594200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.312600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.287800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.123000E-01 |
| Classical-VS-Follicular |
4.577400E-03 |
| Classical-VS-Other |
7.986400E-02 |
| Classical-VS-Normal |
2.031500E-02 |
| Tall-VS-Follicular |
5.803600E-01 |
| Tall-VS-Other |
2.408200E-01 |
| Tall-VS-Normal |
1.299680E-02 |
| Follicular-VS-Other |
4.715000E-01 |
| Follicular-VS-Normal |
3.024900E-04 |
| Other-VS-Normal |
2.077800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.782670E-03 |
| Normal-vs-N1 |
7.238100E-04 |
| N0-vs-N1 |
1.992210E-01 |
|
|
